A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.
Advertisement
The Scientist
Most Recent
The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.
A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.
Researchers say they've found key molecular clues to a problem that plagues 80 percent of men.
Are donors of biological material privy to research results that stem from their donation?
The TB Alliance will test a new combination of drugs to combat normal and multi-drug-resistant tuberculosis.
Over the past 15 years, new laws and regulations in the United States and the European Union have expanded to require the inclusion of pediatric patients in clinical drug trials. Before these laws were enacted, the US Food and Drug Administration (F
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
Vitamin D has a variety of actions in the body. It binds to the vitamin D receptor (VDR), which then binds to the retinoid X receptor (RXR) and activates the expression of numerous genes. Through this mechanism, vitamin D promotes calcium absorption
Studies on safety, efficacy, or dosing of drugs in children, or on nutritional supplements, are not run-of-the-mill.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
